Immune complex-mediated cytokine production is regulated by classical complement activation both in vivo and in vitro

Advances in Experimental Medicine and Biology

Volumn 632, Issue , 2008, Pages 187-201

  Rönnelid, Johan ^a   Åhlin, Erik ^b   Nilsson, Bo ^b   Nilsson Ekdahl, Kristina ^b   Mathsson, Linda ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; CRYOGLOBULIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LA ANTIBODY; RO ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; ANTINUCLEAR ANTIBODY; SS A ANTIBODIES; SS-A ANTIBODIES; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; CELL STIMULATION; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; BIOSYNTHESIS; BLOOD; CELL CULTURE; COMPLEMENT CLASSICAL PATHWAY; IMMUNOLOGY; MONONUCLEAR CELL;

ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; CELLS, CULTURED; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; CRYOGLOBULINS; CYTOKINES; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 58149345112     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78952-1_14     Document Type: Review

References (39)

1. Berger, S., Balló, H. and Stutte, H.J. (1996) Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro- and antiinflammatory cytokines dependent on the antigen-antibody ratio. Eur. J. Immunol. 26, 1297-1301
2. Blom, A.B., Radstake, T.R., Holthuysen, A.E., Sloetjes, A.W., Pesman, G.J., Sweep, F.G., van de Loo, F.A., Joosten, L.A., Barrera, P., van Lent, P.L. and van den Berg, W.B. (2003) Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase. Arthritis Rheum. 48, 1002-1014
3. Braun, M.C., Lahey, E. and Kelsall, B.L. (2000) Selective suppression of IL-12 production by chemoattractants. J. Immunol. 164, 3009-3017
4. Elshafie, A., Ahlin, E., Mathsson, L., Elghazali, G. and Rönnelid, J. (2007) Circulating immune complexes (IC) and IC-induced levels of GM-CSF are increased in Sudanese patients with acute visceral Leishmania donovani infection undergoing sodium stibogluconate treatment: implications for disease pathogenesis. J. Immunol. 178, 5383-5389
5. Elshafie, A., Elghazali, G., Rönnelid, J. and Venge, P. (2006) Cystatin C as a marker of immune complex-associated renal impairment in a Sudanese population with visceral leishmaniasis. Am. J. Trop. Med. Hyg. 75, 864-868
6. Gorczynski, R.M., Kilburn, D.G., Knight, R.A., Norbury, C., Parker, D.C. and Smith, J.B. (1975) Nonspecific and specific immunosuppression in tumour-bearing mice by soluble immune complexes. Nature 254, 141-143
7. Gu, Z.J., Costes, V., Lu, Z.Y., Zhang, X.G., Pitard, V., Moreau, J.F., Bataille, R., Wijdenes, J., Rossi, J.F. and Klein, B. (1996) Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop. Blood 88, 3972-3986
8. Hassan, A.B., Lundberg, I.E., Isenberg, D. and Wahren-Herlenius, M. (2002) Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus. Scand. J. Rheumatol. 31, 133-139
9. Hawlisch, H., Belkaid, Y., Baelder, R., Hildeman, D., Gerard, C. and Kohl, J. (2005) C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity 22, 415-426
10. Hideshima, T., Chauhan, D., Schlossman, R., Richardson, P. and Anderson, K.C. (2001) The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications. Oncogene 20, 4519-4527
11. Jerry, L.M., Lewis, M.G. and Cano, P. (1976) Anergy, anti-antibodies and immune complex disease: a syndrome of disordered immune regulation in human cancer. Immunocancerology in solid tumors. M. Martin and L. Dionne. New York, Stratton, 63-79
12. Kallemuchikkal, U. and Gorevic, P.D. (1999) Evaluation of cryoglobulins. Arch. Pathol. Lab. Med. 123, 119-125
13. Kilburn, D.G., Fairhurst, M., Levy, J.G. and Whitney, R.B. (1976) Synergism between immune complexes and serum from tumor-bearing mice in the suppression of mitogen responses. J. Immunol. 117, 1612-1617
14. Kim, K.N., Watanabe, S., Ma, Y., Thornton, S., Giannini, E.H. and Hirsch, R. (2000) Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer. J. Immunol. 164, 1576-1581
15. Lacki, J.K., Samborski, W. and Mackiewicz, S.H. (1997) Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins. Clin. Rheumatol. 16, 275-278
16. Lauta, V.M. (2003) A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. Cancer 97, 2440-2452
17. Liu, T.F. and Jones, B.M. (1998a) Impaired production of IL-12 in system lupus erythematosus. II: IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFN-gamma and negatively with disease activity in SLE. Cytokine 10, 148-153
18. Liu, T.F. and Jones, B.M. (1998b) Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes. Cytokine 10, 140-147
19. Liu, T.F., Jones, B.M., Wong, R.W. and Srivastava, G. (1999) Impaired production of IL-12 in systemic lupus erythematosus. III: deficient IL-12 p40 gene expression and crossregulation of IL-12, IL-10 and IFN-gamma gene expression. Cytokine 11, 805-811
20. Llorente, L., Richaud-Patin, Y., Wijdenes, J., Alcocer-Varela, J., Maillot, M.C., Durand- Gasselin, I., Fourrier, B.M., Galanaud, P. and Emilie, D. (1993) Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Netw. 4, 421-427
21. Lövgren, T., Eloranta, M.L., Bave, U., Alm, G.V. and Rönnblom, L. (2004) Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 50, 1861-1872
22. Lu, Z.Y., Zhang, X.G., Rodriguez, C., Wijdenes, J., Gu, Z.J., Morel-Fournier, B., Harousseau, J.L., Bataille, R., Rossi, J.F. and Klein, B. (1995) Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. Blood 85, 2521-2527
23. Mathsson, L., Tejde, A., Carlson, K., Höglund, M., Nilsson, B., Nilsson-Ekdahl, K. and Rönnelid, J. (2005) Cryoglobulin-induced cytokine production via FcgRIIa: inverse effects of complement blockade on the production of TNF-a and IL-10. Implications for the growth of malignant B-cell clones. Br. J. Haematol. 129, 830-838
24. Mathsson, L., Lampa, J., Mullazehi, M. and Rönnelid, J. (2006) Immune complexes from rheumatoid arthritis synovial fluid induce FcgRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells. Arthritis Res. Ther. Mar 28;8(3):R64 [Epub ahead of print] doi:10.1186/ar1926
25. Mathsson, L., Ahlin, E., Sjövall, C., Skogh, T. and Rönnelid, J. (2007) Cytokine induction by circulating immune complexes and signs of in-vivo complement activation in systemic lupus erythematosus are associated with the occurrence of anti-SSA antibodies. Clin. Exp. Immunol. 147, 513-520
26. McInnes, I.B. and Schett, G. (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429-442
27. Mullazehi, M., Mathsson, L., Lampa, J. and Rönnelid, J. (2006) Surface-bound anti-type II collagen containing immune complexes induce production of TNF-a, IL-1ß and IL-8 from peripheral blood monocytes via FcgRIIa. A potential patho-physiologicalmechanism for humoral anti-collagen type II immunity in RA. Arthritis Rheum. 54, 1759-1771
28. Nilsson, U.R. (2001) Deposition of C3b/iC3b leads to the concealment of antigens, immunoglobulins and bound C1q in complement-activating immune complexes. Mol. Immunol. 38, 151-160
29. Park, Y.B., Lee, S.K., Kim, D.S., Lee, J., Lee, C.H. and Song, C.H. (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin. Exp. Rheumatol. 16, 283-288
30. Peeva, E., Fishman, A.D., Goddard, G., Wadler, S. and Barland, P. (2000) Rheumatoid arthritis exacerbation caused by exogenous interleukin-12. Arthritis Rheum. 43, 461-463
31. Radstake, T., van Lent, P.L.E.M., Pesman, G.J., Blom, A.B., Sweep, F.G.J., Rönnelid, J., Figdor, C.G., Adema, G.J., Barrera, P. and van den Berg, W.B. (2004) High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon Fc{gamma}R triggering. Ann. Rheum. Dis. 63, 696-702
32. Rönnelid, J., Tejde, A., Mathsson, L., Nilsson-Ekdahl, K. and Nilsson, B. (2003) Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE. Ann. Rheum. Dis. 62, 37-42
33. Sahu, A., Soulika, A.M., Morikis, D., Spruce, L., Moore, W.T. and Lambris, J.D. (2000) Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J. Immunol. 165, 2491-2499
34. Segal-Eiras, A. and Croce, M.V. (1984) Immune complexes in human malignant tumours. A review. Allergol. Immunopathol. (Madr) 12, 225-232
35. Tarkowski, A., Czerkinsky, C. and Nilsson, L.A. (1985) Simultaneous induction of rheumatoid factor- and antigen-specific antibody-secreting cells during the secondary immune response in man. Clin. Exp. Immunol. 61, 379-387
36. Tejde, A., Mathsson, L., Nilsson Ekdahl, K., Nilsson, B. and Rönnelid, J. (2004) Immune complex stimulation of peripheral blood mononuclear cells result in enhancement or suppression of IL-12 production dependent on serum factors. Role of complement activation. Clin. Exp. Immunol. 137, 521-528
37. Urbanska-Rys, H., Wiersbowska, A., Stepien, H. and Robak, T. (2000) Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma. Eur. Cytokine Netw. 11, 443-451
38. Weiner, S.M., Prasauskas, V., Lebrecht, D., Weber, S., Peter, H.H. and Vaith, P. (2001) Occurrence of C-reactive protein in cryoglobulins. Clin. Exp. Immunol. 125, 316-322
39. Wittmann, M., Zwirner, J., Larsson, V.A., Kirchhoff, K., Begemann, G., Kapp, A., Gotze, O. and Werfel, T. (1999) C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. J. Immunol. 162, 6763-6769